Fig. 2: Intermittent OCS use by GINA Step at initial OCS prescription among UK patients with asthma.
From: Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma

GINA Global Initiative for Asthma; ICS, inhaled corticosteroid; LABA, long-acting β2 agonist; OCS, oral corticosteroid; PRN, as-needed; SABA, short-acting β2 agonist. For GINA Step 5 treatment, ‘+’ refers to add-on therapy with e.g., tiotropium, anti-IgE, anti-IL5/5R or anti-IL4R therapies.